Health care law organization Frier Levitt has analyzed FDA enforcement actions in opposition to “analysis only” peptide distributors. Their summary: the FDA considers a product’s classification determined by its meant use, not its disclaimers. When websites incorporate dosage guides, reconstitution Recommendations, or url to boards speaking a